New Data Highlights BeyondSpring’s Plinabulin as a Highly Effective Agent for Preventing Chemotherapy-Induced Neutropenia, with Potential to Reduce…

As you were browsing http://www.streetinsider.com something about your browser made us think you were a bot. If you are interested in http://www.streetinsider.com content, APIs are available. Please contact us here http://www.streetinsider.com/signup_content.php After completing the CAPTCHA below, you will immediately regain access to http://www.streetinsider.com

Read more
Get Up to Speed On the State of Eco-Fashion – NEO.LIFE

In December 2019, an odd new product hit the headlines. Called FLWRDWN, unlike every other fashion material innovation youve read about that always seem to be years out of reach, the mixture of waste wildflowers, biopolymer, and a patented cellulosic aerogel debuted to the world ready to be worn, encased inside a fashionable nylon puffer coat.

Read more
Advances in the Treatment of Mantle Cell Lymphoma are Greatly Improving the Long-Term Outlook for Patients – Curetoday.com

When James Landon received a mantle cell lymphoma (MCL) diagnosis in 2017, he was told his disease was indolent, meaning it was slow growing and didnt need to be treated right away, especially since he was feeling fine. But that changed in 2019. Landon, 50, an attorney in Tucson, Arizona, started to feel tired all the time.

Read more
Global Cord Blood Banking Market is Anticipate to Reach at a CAGR of 5.5% during the forecast period – PharmiWeb.com

A new research report published by Fior Markets with the titleCord Blood Banking Market by Type of Bank (Public, Private), Services (Processing, Storage), Application (Cancer, Blood Disorders, Immuno-deficiency Disorders, Metabolic Disorders, Bone Marrow Failure Syndrome), End-User (Hospitals, Research Institutes, Specialty Clinics), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027. Theglobal cord blood banking marketis expected to grow from USD 16.88 billion in 2019 to USD 25.90 billion by 2027, at a CAGR of 5.5% during the forecast period 2020-2027. The North America region dominates the market and holds the largest share in the year 2019

Read more
Bioprinted therapeutic offers novel solution for treating Type 1 Diabetes – Canada NewsWire

Current treatments for diabetes are costlywith diabetes-related healthcare costs in Canada expected to increase to over $16.9 billion by 2020.They carry costs for patients as well, frequently in the form of negative side effects. One conventional method of treating T1D is the daily administration of insulin to manage blood sugar levels.

Read more